arrow_circle_up

We develop strategies that enable enzymes to catalyze reactions that are currently unknown in nature.

We are working to establish visible light irradiation as a general strategy for unlocking new catalytic functions from enzymes. Using the redox formalisms commonly used by synthetic chemists, we can design valuable chemical reactions that nature has never envisioned that solve long standing challenges in chemical synthesis.

Discovering versatile biocatalysis that can be used to accelerate the synthesis of drugs and agrochemicals.

Based in the Frick Chemistry Laboratory at Princeton University, the Hyster lab integrates the fields of organic synthesis, organometallic chemistry, chemical biology, and protein engineering to develop new biocatalytic reactions that solve longstanding selectivity challenges and expand how enzymes can be used to achieve sustainable chemical synthesis.

arrow_circle_left arrow_circle_right
●○○

Using photoenzymatic catalysis to unlock new synthetic reactions.

Our approach provides access to enantioselective transformations involving radicals that are currently unmatched by organocatalysts and transition metal catalysts.

arrow_circle_left arrow_circle_right
○●○

Harnessing enzymes for streamlined organic synthesis.

We use the retrosynthetic disconnections available to enzymes to accelerate the synthesis of molecules with medicinal and biological relevance.

arrow_circle_left arrow_circle_right
○○●

Building artificial enzymes with emergent functions.

We are merging enzymes with transition metal complexes to develop biohydrids with functions that are unrealized by either the enzyme or metal alone.

Recent publications.

  • Pyridoxal photoenzymes for asymmetric radical–radical cross-couplings

    Cole C. Sorensen, Suhao Wang, Yao Ouyang, Saim Waheed, Claire G. Page, Greg Mann, Simon Allmendinger & Todd K. Hyster 

    Nature, 2026, 657, 142-149

    Publication Abstract

    Non-native photoenzymes have enabled a myriad of asymmetric bond-forming events that are otherwise challenging or currently impossible with small molecule catalysis. These reactions require enzymes with cofactors that are strong absorbers in the visible region with reasonably long-lived excited states, such as flavin and nicotinamide. However, there exists a substantial chromophoric cofactor “dark space” where no known photoenzymatic activity has been characterized. Increased knowledge of the photophysics of the cofactors in the “dark space” would increase the types of bonds that photoenzymes can form by accessing new excited state intermediates in enzyme classes with divergent reactivities and selectivities. Here, we establish pyridoxal 5’-phosphate (PLP) as a photoenzymatic cofactor by leveraging the excited state quinonoid intermediate as a potent single-electron reductant. We overcome the poor photophysical properties of the native quinonoid intermediate by employing non-native benzyl amine substrates and exploiting Förster resonance energy transfer mechanism from an exogenous photosensitizer to access the quinonoid excited state. This redox neutral approach enables an asymmetric radical-radical cross-coupling between benzyl amines and reductive radical precursors through concomitant generation and localization of a radical pair in an enzyme active site—overcoming the typical challenges associated with this reaction by removing the necessity for radical sorting and the persistent radical effect. The emergent photoexcited intermediates of PLP identified in this work greatly expands the potential avenues for valuable bond forming events by PLP-dependent enzymes.

  • Asymmetric Hydroamination Using Oxidative Radical Initiation in Flavin Enzymes

    Alexandra C. Brown, Carlos E. Del Angel Aguilar, Felix C. Raps, Paul S. Riehl, Todd K. Hyster*

    J. Am. Chem. Soc., 2026, 148, 25, 25945–25956

    Publication Abstract

    Asymmetric radical alkene hydroamination offers a potentially powerful strategy to form enantioenriched, saturated N-heterocycles, but these reactions have proved challenging to render stereoselective. Here, we report an engineered flavin enzyme that catalyzes the formation of chiral pyrrolidines with high yield and enantioselectivity. Development of this transformation addresses a long-standing limitation in flavin photobiocatalysis: the short lifetime of the photoexcited flavin quinone has previously made it challenging to leverage this species as a photooxidant. We report that the photophysical properties of a flavin enzyme can be tuned via rational mutagenesis to obtain a variant with a long-lived excited state, and that this enzyme can be further engineered to create an efficient catalyst for asymmetric radical hydroaminations. Moreover, this work introduces two mechanistic discoveries that can be applied broadly in photobiocatalysis: (1) an exogeneous cophotocatalyst can serve as a photoprotectant for the enzymatic cofactor and (2) enantiospecific termination of chiral radical intermediates provides a mechanism to achieve stereocontrol over previously challenging classes of transformations.

  • Photoenzymatic Hydroalkylation Enables Streamlined Access to Aryl Glutarimide Precursors

    Zhi Xu, Prasun Mukherjee, Steven Gossert, Stephen Thomas, Vasil H. Vasilev, Eric R. Welin, Yichen Tan, Shane M. McKenna, Megan A. Emmanuel, Todd K. Hyster

    Angew. Chem. Int. Ed., 2026, e00006

    Publication Abstract

    We describe a photoenzymatic hydroalkylation reaction that enables the efficient and stereocontrolled synthesis of aryl glutarimide precursors—chemically and configurationally robust entry points to bioactive agents for targeted protein degradation. Screening of flavin-dependent “ene”-reductases identified GluER HArac, a G. oxydans variant, as an efficient and substrate-tolerant catalyst, granting access to >30 (hetero)aryl glutarimide precursors. A directed evolution campaign then furnished a hexamutant, GluER HAent, that delivers the products in up to 93:7 enantiomeric ratio. Mechanistic experiments revealed a pathway that departs from the hydrogen atom transfer mechanism previously established for related systems, proceeding instead via radical–polar crossover followed by enantioselective proton transfer from an active-site tyrosine residue. Collectively, these studies establish a biocatalytic platform for advancing the synthesis and diversification of glutarimide-containing degraders.

Our team.

The Hyster Lab is led by Principal Investigator, Todd Hyster. Our research team comprises a group of exceptional post-doctoral associates and fellows, graduate students, and undergraduates.

Hyster Lab logo avatar bulb cap Hyster Lab logo avatar filament Hyster Lab logo avatar arrows